HbA1c Testing Devices Market Size to Reach $4.36 Billion by 2034, Growing at 6.4% CAGR

The global HbA1c testing devices market was valued at approximately USD 2.34 billion in 2024 and is expected to reach around USD 4.36 billion by 2034

PUNE, MAHARASHTRA, INDIA, August 11, 2025 /EINPresswire.com/ -- 📊 Global HbA1c Testing Devices Market Research Report (2025–2034)-Market Size, Share, Trends, Growth Drivers, Challenges, Regional Insights, and Forecast

1. Executive Summary
The Global HbA1c Testing Devices Market Size was valued at approximately USD 2.34 billion in 2024 and is projected to reach USD 4.36 billion by 2034, expanding at a CAGR of 6.40% between 2025 and 2034.
HbA1c (Glycated Hemoglobin) testing is a critical diagnostic and monitoring tool for diabetes management, reflecting the average blood glucose levels over the past 2–3 months. The market growth is driven by the rising prevalence of diabetes, increasing adoption of point-of-care testing devices, technological advancements, and growing healthcare awareness.

Elevate your business strategy with comprehensive market data. Request a sample report now: https://www.zionmarketresearch.com/sample/hba1c-testing-devices-market

2. Market Overview
HbA1c testing is a key parameter for diagnosing diabetes and pre-diabetes as well as assessing long-term glycemic control in diabetic patients. With diabetes becoming one of the top global health challenges, the demand for HbA1c testing devices is increasing across hospitals, clinics, diagnostic laboratories, and home care settings.

Key Insights:
As per the analysis shared by our research analyst, the global HbA1c testing devices market is estimated to grow annually at a CAGR of around 6.40% over the forecast period (2025-2034)
In terms of revenue, the global HbA1c testing devices market size was valued at around USD 2.34 billion in 2024 and is projected to reach USD 4.36 billion by 2034.
The HbA1c testing devices market is projected to grow significantly due to the increasing adoption of point-of-care testing and technological advancements in diagnostic accuracy and speed.
Based on product type, point-of-care testing devices lead the segment and are expected to continue dominating the global market.
Based on the technology, immunoassay is expected to lead the market.
Based on the end user, hospitals are anticipated to command the largest market share.
Based on application, diabetes management is expected to lead the market during the forecast period.
Based on region, North America is projected to lead the global market during the forecast period.

The market is characterized by:
Innovation in testing technologies (lab-based & point-of-care)
Integration with digital health platforms
Growing adoption in emerging economies
Expanding role in preventive health check-ups

Do You Have Any Query Or Specific Requirement? Request Customization of Report: https://www.zionmarketresearch.com/custom/9575

3. Market Size & Forecast (USD Billion)
Year Market Size
2024- 2.34
2025- 2.48
2026- 2.64
2027- 2.81
2028- 3.00
2029- 3.20
2030- 3.41
2031- 3.64
2032- 3.89
2033- 4.13
2034- 4.36

CAGR (2025–2034): 6.40% 📈

4. Key Growth Drivers 🚀
Rising Global Diabetes Prevalence
According to the International Diabetes Federation, over 537 million adults were living with diabetes in 2021, projected to reach 643 million by 2030.
This surge directly fuels HbA1c testing demand.
Shift to Preventive Healthcare
More individuals are opting for preventive screenings, where HbA1c is a critical biomarker.
Technological Innovations
Portable, user-friendly point-of-care devices and lab automation are making testing faster and more accurate.
Government Screening Programs
National health campaigns targeting diabetes detection are boosting testing volumes.

5. Challenges & Restraints ⚠️
High cost of advanced HbA1c analyzers in low-income countries.
Lack of awareness in rural regions about diabetes screening.
Reimbursement issues in certain healthcare systems.
Competition from alternative glucose monitoring technologies, like Continuous Glucose Monitoring (CGM).

6. Market Segmentation
By Product Type
Laboratory-based HbA1c Testing Devices
Point-of-Care (POC) HbA1c Devices

By Technology
Ion-Exchange High Performance Liquid Chromatography (HPLC)
Immunoassay
Boronate Affinity Chromatography
Other Emerging Methods

By End User
Hospitals & Clinics
Diagnostic Laboratories
Home Care Settings

7. Regional Analysis 🌍
The market’s growth potential varies significantly by geography due to healthcare infrastructure, awareness levels, and diabetes prevalence.

🔹 North America
2024 Size: USD 0.91 Billion
2034 Projection: USD 1.66 Billion
CAGR: ~6.3%

Key Factors:
High diabetes incidence
Strong insurance coverage
Advanced healthcare infrastructure
Dominance of leading diagnostic companies (Abbott, Bio-Rad, Siemens)

🔹 Europe
2024 Size: USD 0.65 Billion
2034 Projection: USD 1.18 Billion
CAGR: ~6.1%

Key Factors:
Universal healthcare systems
Aging population
Strong government-backed screening programs

🔹 Asia-Pacific (APAC)
2024 Size: USD 0.52 Billion
2034 Projection: USD 1.03 Billion
CAGR: ~7.2% (Fastest Growing Region)

Key Factors:
Rising middle-class population
High undiagnosed diabetes rate
Expanding private healthcare sector

🔹 Latin America
2024 Size: USD 0.16 Billion
2034 Projection: USD 0.30 Billion
CAGR: ~6.4%

Key Factors:
Increasing urbanization & lifestyle changes
Growing access to private diagnostics

🔹 Middle East & Africa (MEA)
2024 Size: USD 0.10 Billion
2034 Projection: USD 0.19 Billion
CAGR: ~6.5%

Key Factors:
Rising obesity rates
Government focus on chronic disease management

Inquiry For Buying- https://www.zionmarketresearch.com/inquiry/hba1c-testing-devices-market

8. Competitive Landscape 🏢
The global HbA1c testing devices market is led by players like:

Abbott Laboratories
Roche Diagnostics
Siemens Healthineers
Bio-Rad Laboratories Inc.
Tosoh Corporation
Arkray Inc.
PTS Diagnostics
Bayer AG
Beckman Coulter Inc.
Trinity Biotech
Erba Diagnostics Mannheim GmbH
EKF Diagnostics Holdings plc
Diasys Diagnostic Systems GmbH
Transasia Bio-Medicals Ltd.
Mindray Medical International Limited
Danaher Corporation
Thermo Fisher Scientific Inc.
PerkinElmer Inc.
Ortho Clinical Diagnostics
Quidel Corporation

Recent Developments:
Abbott launched a next-gen HbA1c analyzer with improved accuracy and faster turnaround times (2024).
Siemens partnered with a leading telehealth provider to integrate HbA1c testing into remote diabetes monitoring.

9. Future Trends 🔮
AI & Digital Health Integration: AI-powered platforms predicting diabetes risk based on HbA1c and lifestyle data.
Self-Testing Kits: Rise of home-based HbA1c testing with telemedicine support.
Emerging Market Expansion: Focus on affordability and accessibility in developing nations.

10. Conclusion
The HbA1c Testing Devices Market is on a strong growth trajectory, powered by the rising diabetes burden, increasing focus on preventive healthcare, and technological advancements. With innovations in point-of-care testing and integration into digital health ecosystems, the next decade will see broader adoption across both developed and developing markets.

✅ Final Outlook:

Base Year (2024): USD 2.34 Billion
Forecast Year (2034): USD 4.36 Billion
CAGR (2025–2034): 6.40%
Growth Opportunities: Digital health integration, emerging markets, self-testing devices

More Trending Reports by Zion Market Research -
Roadside Drug Testing Devices Market
Hemoglobin Testing Devices Market

Browse Other Related Research Reports from Zion Market Research-

Breast Cancer Mammography Screening Market By Type (Screening Mammography, Diagnostic Mammography), By Product (Film-Screen Mammography, Full-Field Digital Mammography [FFDM], 3D Breast Tomosynthesis, Cone Beam Breast CT [CBCT], and Others), By Technology (Analog Mammography, Digital Mammography, 3D Mammography, and Others), By End-User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034-https://www.zionmarketresearch.com/report/breast-cancer-mammography-screening-market

Sacral Neuromodulation Market By Product Type (Implantable Pulse Generators, Leads and Electrodes, External Pulse Generators, and Accessories), By Application (Overactive Bladder, Fecal Incontinence, Urinary Retention, and Chronic Pelvic Pain), By Distribution Channel (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Direct Sales), By End-User (Urology Clinics, Gastroenterology Centers, Pain Management Clinics, and Rehabilitation Centers), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034-https://www.zionmarketresearch.com/report/sacral-neuromodulation-market

Surgical Needle Holders Market By Product Type (Locking Needle Holders, Non-Locking Needle Holders, Micro Needle Holders, and Disposable Needle Holders), By Application (General Surgery, Cardiovascular Surgery, Plastic Surgery, and Orthopedic Surgery), By Distribution Channel (Hospitals, Surgical Centers, Medical Device Distributors, and Online Medical Platforms), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Veterinary Practices), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034-https://www.zionmarketresearch.com/report/surgical-needle-holders-market

Surgical Sutures Market By Product Type (Absorbable Sutures, Non-Absorbable Sutures, Barbed Sutures, and Antimicrobial Sutures), By Application (Cardiovascular Surgery, General Surgery, Orthopedic Surgery, and Cosmetic Surgery), By Distribution Channel (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Online Medical Suppliers), By End-User (Hospitals, Surgical Centers, Clinics, and Emergency Care Facilities), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034 -https://www.zionmarketresearch.com/report/surgical-sutures-market-size

Reusable Blood Hemodialyzer Market By Type (High-flux Dialyzers, Low-flux Dialyzers), By Usage (Disposable Dialyzers, Reusable Dialyzers), By End-User (Hospitals, Dialysis Centers, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034-https://www.zionmarketresearch.com/report/reusable-blood-hemodialyzer-market

Nuclear Medicine Radiopharmaceuticals Market By Product Type (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals, Enriched Stable Isotopes, and Medical Radioisotopes), By Application (Oncology, Cardiology, Neurology, and Nephrology), By Distribution Channel (Hospital Pharmacies, Nuclear Pharmacies, Retail Pharmacies, and Online Pharmacies), By End User (Hospitals, Diagnostic Centers, Research Institutes, and Academic Centers), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034-https://www.zionmarketresearch.com/report/nuclear-medicine-radiopharmaceuticals-market-size

Deepak Rupnar
Zion Market Research
+1 855-465-4651
richard@zionmarketresearch.com
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.